Related Experiment Video
Updated: Mar 26, 2026
12:01
The Superficial Inferior Epigastric Artery Fascia Flap for Nerve Reconstruction in Rabbits
Published on: June 13, 2025
1.2K
Donor site morbidity in buccinator-based myomucosal flaps: A retrospective study
Amin Rahpeyma1, Saeedeh Khajehahmadi2
1Oral and Maxillofacial Diseases Research Center, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
Asian Journal of Surgery
|January 21, 2016
Summary
Buccinator myomucosal flaps have low donor site morbidity for head and neck reconstructions. Minimal mouth opening reduction occurred in 20% of patients, indicating a safe reconstructive option.
Area of Science:
- Reconstructive surgery
- Oral and maxillofacial surgery
- Plastic surgery
Background:
- Buccinator-based myomucosal flaps are utilized for reconstructions in the oral cavity, pharynx, esophagus, and nasal passages.
- Evaluating donor site morbidity is crucial for flap selection in reconstructive procedures.
Purpose of the Study:
- To assess the donor site morbidity associated with buccinator-based myomucosal flaps.
- To identify potential complications and their impact on patients undergoing reconstruction.
Main Methods:
- A retrospective study reviewed patients who underwent reconstruction using buccinator-based myomucosal flaps between 2008 and 2012.
- Evaluated donor site morbidity, including maximal interincisal opening (MIO), mandibular vestibule obliteration, Stensen duct injury, and buccal mucosa fibrous bands.
Main Results:
- Twenty-two flaps were used in 20 patients for oral, nasal, or oropharyngeal reconstruction.
- The Facial Artery Musculomucosal (FAMM) flap was most common (50%), often for cleft lip/palate sequelae (45%).
- Four patients experienced complications, specifically a minimal reduction in MIO.
Conclusions:
- Buccinator-based myomucosal flaps demonstrate low donor site morbidity.
- A small percentage of patients (20%) experienced a minor decrease in mouth opening.
